PFIZER EXPANDING U.S. DETAIL FORCE TO OVER 3,000 REPS BY YEAR-END, COMPANY TELLS ANALYSTS; PFIZER NOT INTERESTED IN "MEGA-ACQUISITION" FOR INTERNATIONAL GROWTH
TX Pfizer is creating a fourth pharmaceutical sales force that will give the company more than 3,000 sales reps in the U.S., Pfizer Exec VP Henry McKinnell, PhD, told a securities analysts meeting in New York City Aug. 6.
You may also be interested in...
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials
Specialty drug maker Shire has quietly begun scouting deals with a brand-new $50 million venture fund, the latest of several in-house investment arms to launch with their parent company's pipelines, not profits, as the measure of their worth